Related Experiment Video
Updated: Aug 5, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Peritoneal Mesothelioma in a High Volume Peritoneal Surface Malignancies Unit
Fernando Pereira1,2, Mónica Pereira2, Israel Manzanedo1,2
1Peritoneal Surface Malignancies Unit, Department of Surgery, Hospital Universitario de Fuenlabrada, 28942 Madrid, Spain.
Abstract:
Diffuse malignant peritoneal mesothelioma (PM) is a rare neoplasm, traditionally associated with a poor prognosis. There are other varieties of PM that are even less frequent and of uncertain malignancy. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has achieved prolonged survival in selected patients. The aim of this study is to analyze the patients with PM assessed in our center. Clinicopathological characteristics, diagnostic procedures and survival results from patients with PM appraised at our unit, according to the applied treatment, were analyzed. Seventeen patients were assessed between 2007 and 2019. Three cases had multicystic PM that were treated with complete CRS + HIPEC; all patients are alive and free of disease after a long follow-up. Three other cases had biphasic PM; a curative treatment could be performed in none of them, and their survival was minimal (<6 moths). Lastly, 11 cases with epithelioid PM were treated. Two cases were considered unresectable at laparoscopy (PCI 39); one of them had a long survival (67 months) with three iterative laparoscopic palliatives HIPECs for refractory ascites. The other nine cases were treated with curative CRS + HIPEC, with a median PCI of 14 (range 4-25), and a median overall survival (OS) of 58 months, with a 5-year OS of 47.4%. In conclusion, CRS + HIPEC, when possible, appears to be the optimal treatment for patients with PM. Knowledge of this therapeutic option is crucial, both to offer it to patients and to avoid delays in their referral to appropriate centers for treatment.
Insights
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) offers prolonged survival for peritoneal mesothelioma (PM) patients. This treatment, when feasible, is optimal for PM management, improving patient outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Peritoneal mesothelioma (PM) is a rare cancer with a historically poor prognosis.
- Less common PM subtypes exist with uncertain malignancy.
- Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promise for prolonged survival in select patients.
Purpose of the Study:
- To analyze clinicopathological characteristics, diagnostic methods, and survival outcomes of peritoneal mesothelioma patients treated at our center.
- To evaluate the effectiveness of different treatment modalities for various PM subtypes.
Main Methods:
- Retrospective analysis of 17 peritoneal mesothelioma patients treated between 2007 and 2019.
- Assessment of clinicopathological data, diagnostic procedures, and treatment responses.
- Surgical interventions included complete cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC).
Main Results:
- Multicystic PM treated with CRS + HIPEC showed complete disease-free survival.
- Biphasic PM had limited survival (<6 months) with no curative treatment options.
- Epithelioid PM treated with curative CRS + HIPEC achieved a median overall survival of 58 months (47.4% 5-year OS).
- One unresectable epithelioid PM case had long survival (67 months) with palliative HIPEC for ascites.
Conclusions:
- Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) is the optimal treatment for eligible peritoneal mesothelioma (PM) patients.
- Timely referral to specialized centers for CRS + HIPEC is crucial for improving PM patient outcomes.
- Further research into managing unresectable and rare PM subtypes is warranted.
More Related Videos
Related Concept Videos
Pleural Disorders: Types and Brief Description
Peritoneum
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
Pleura of the Lungs

